<DOC>
	<DOCNO>NCT00840918</DOCNO>
	<brief_summary>This study do determine lidocaine , administer surgery 24 hour surgery reduce inflammation , thereby reduce risk atrial fibrillation 30 day mortality surgery . Participants undergo cardiac surgery randomize receive either lidocaine placebo .</brief_summary>
	<brief_title>Intravenous Lidocaine Postoperative Outcomes After Cardiac Surgery</brief_title>
	<detailed_description>Subjects undergoing cardiac surgery randomize one two group . - Group 1 : Intravenous Lidocaine Group - Group 2 : Intravenous placebo Group Either Lidocaine placebo administer throughout surgery 24 hour surgery . Patients group undergo quality life assessment functional recovery assessment post-surgery .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<criteria>Age 1890 year old Scheduled cardiac surgery require cardiopulmonary bypass Written inform consent Offpump surgical procedure Anticipated deep hypothermic circulatory arrest Any contraindication propose intervention include lidocaine allergy History preoperative atrial fibrillation Baseline Screening reveal preexist dementia delirium Preoperative liver failure define ChildPugh Score &gt; 6</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Cardiac surgery</keyword>
	<keyword>Lidocaine</keyword>
	<keyword>Quality life</keyword>
</DOC>